Roolf C - Search Results

1

PDA Indolylmaleimides Induce Anti-Tumor Effects in Prostate Carcinoma Cell Lines Through Mitotic Death.

Schille JT, Nolte I, Beck J, Jilani D, Roolf C, Pews-Davtyan A, Rolfs A, Henze L, Beller M, Brenig B, Junghanss C, Schütz E, Murua Escobar H. Schille JT, et al. Among authors: roolf c. Front Vet Sci. 2021 Jan 20;7:558135. doi: 10.3389/fvets.2020.558135. eCollection 2020. Front Vet Sci. 2021. PMID: 33553272 Free PMC article.

2

Characterization of the novel indolylmaleimides' PDA-66 and PDA-377 effect on canine lymphoma cells.

Liu W, Beck J, Schmidt LC, Roolf C, Pews-Davtyan A, Rütgen BC, Hammer S, Willenbrock S, Sekora A, Rolfs A, Beller M, Brenig B, Nolte I, Junghanss C, Schütz E, Murua Escobar H. Liu W, et al. Among authors: roolf c. Oncotarget. 2016 Jun 7;7(23):35379-89. doi: 10.18632/oncotarget.9297. Oncotarget. 2016. PMID: 27177088 Free PMC article.

3

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells.

Kretzschmar C, Roolf C, Langhammer TS, Sekora A, Pews-Davtyan A, Beller M, Frech MJ, Eisenlöffel C, Rolfs A, Junghanss C. Kretzschmar C, et al. Among authors: roolf c. BMC Cancer. 2014 Feb 6;14:71. doi: 10.1186/1471-2407-14-71. BMC Cancer. 2014. PMID: 24502201 Free PMC article.

4

Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.

Taher L, Beck J, Liu W, Roolf C, Soller JT, Rütgen BC, Hammer SE, Chodisetti M, Sender S, Sterenczak KA, Fuellen G, Junghanss C, Brenig B, Nolte I, Schütz E, Murua Escobar H. Taher L, et al. Among authors: roolf c. Sci Rep. 2018 Apr 19;8(1):6279. doi: 10.1038/s41598-018-23207-7. Sci Rep. 2018. PMID: 29674676 Free PMC article.

5

Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse.

Gladbach YS, Sklarz LM, Roolf C, Beck J, Schütz E, Fuellen G, Junghanss C, Murua Escobar H, Hamed M. Gladbach YS, et al. Among authors: roolf c. Genes (Basel). 2022 Jul 14;13(7):1240. doi: 10.3390/genes13071240. Genes (Basel). 2022. PMID: 35886023 Free PMC article.

6

Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines.

Sklarz LM, Gladbach YS, Ernst M, Hamed M, Roolf C, Sender S, Beck J, Schütz E, Fischer S, Struckmann S, Junghanss C, Fuellen G, Murua Escobar H. Sklarz LM, et al. Among authors: roolf c. Cancer Cell Int. 2020 Aug 12;20:390. doi: 10.1186/s12935-020-01431-4. eCollection 2020. Cancer Cell Int. 2020. PMID: 32817744 Free PMC article.

7

Comparative characterization of stem cell marker expression, metabolic activity and resistance to doxorubicin in adherent and spheroid cells derived from the canine prostate adenocarcinoma cell line CT1258.

Liu W, Moulay M, Willenbrock S, Roolf C, Junghanss C, Ngenazahayo A, Nolte I, Murua Escobar H. Liu W, et al. Among authors: roolf c. Anticancer Res. 2015 Apr;35(4):1917-27. Anticancer Res. 2015. PMID: 25862843

8

Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.

Richter A, Fischer E, Holz C, Schulze J, Lange S, Sekora A, Knuebel G, Henze L, Roolf C, Murua Escobar H, Junghanss C. Richter A, et al. Among authors: roolf c. Int J Mol Sci. 2021 Mar 9;22(5):2771. doi: 10.3390/ijms22052771. Int J Mol Sci. 2021. PMID: 33803402 Free PMC article.

9

Graft-versus-Host Disease in a Dog After Reduced-intensity Hematopoietic Stem Cell Transplantation from a DLA-identical Littermate.

Schaefer S, Werner J, Lange S, Machka C, Knuebel G, Sekora A, Roolf C, Winkler T, Murua Escobar H, Nolte I, Junghanss C. Schaefer S, et al. Among authors: roolf c. In Vivo. 2016 Jul-Aug;30(4):427-32. In Vivo. 2016. PMID: 27381604

10

Phosphoproteome Analysis Reveals Differential Mode of Action of Sorafenib in Wildtype and Mutated FLT3 Acute Myeloid Leukemia (AML) Cells.

Roolf C, Dybowski N, Sekora A, Mueller S, Knuebel G, Tebbe A, Murua Escobar H, Godl K, Junghanss C, Schaab C. Roolf C, et al. Mol Cell Proteomics. 2017 Jul;16(7):1365-1376. doi: 10.1074/mcp.M117.067462. Epub 2017 Apr 27. Mol Cell Proteomics. 2017. PMID: 28450419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page